After talks with FDA, a biotech prepares to submit its closely watched ALS drug

Submitted by admin on September 15, 2021 - 10:48am

Source:

BioPharma Dive

News Tags:

Amylyx Pharmaceuticals

FDA

ALS

AMX-0035

Headline:

After talks with FDA, a biotech prepares to submit its closely watched ALS drug

snippet:

Amylyx Pharmaceuticals, a Massachusetts-based drug developer, announced Wednesday it plans to ask U.S. regulators in the "coming months" to approve an experimental and closely watched treatment for ALS.

Search form

You are here

After talks with FDA, a biotech prepares to submit its closely watched ALS drug

After talks with FDA, a biotech prepares to submit its closely watched ALS drug